These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 535604)

  • 1. A comparison of the chemosensitivity of a primary tumour and its metastases using a human tumour xenograft.
    Selby PJ; Thomas JM; Peckham MJ
    Eur J Cancer (1965); 1979 Dec; 15(12):1425-9. PubMed ID: 535604
    [No Abstract]   [Full Text] [Related]  

  • 2. Melphalan uptake in relation to vascular and extracellular space of human lung-tumour xenografts.
    Wist E; Millar JL; Shorthouse AJ
    Br J Cancer; 1981 Apr; 43(4):458-63. PubMed ID: 6263305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A lung colony clonogenic cell assay for human malignant melanoma in immune-suppressed mice and its use to determine chemosensitivity, radiosensitivity and the relationship between tumour size and response to therapy.
    Thomas JM
    Br J Surg; 1979 Oct; 66(10):696-700. PubMed ID: 509043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limitations of the human tumour xenograft system in individual patient drug sensitivity testing.
    Bailey MJ; Jones AJ; Shorthouse AJ; Raghaven D; Selby P; Gibbs J; Peckham MJ
    Br J Cancer; 1984 Nov; 50(5):721-4. PubMed ID: 6498071
    [No Abstract]   [Full Text] [Related]  

  • 5. In vivo-in vitro clonogenic assays in a human tumour xenograft with a high plating efficiency.
    Warenius HM; Bleehen NM
    Br J Cancer; 1982 Jul; 46(1):45-50. PubMed ID: 7104196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combination of melphalan with prednisolone. Anti-tumor effect and normal tissue toxicity in laboratory systems.
    Selby PJ; Millar JL; Phelps TA; Gordon MY; Wilkinson R; McElwain TJ
    Cancer Chemother Pharmacol; 1981; 6(2):169-73. PubMed ID: 7307234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combination of methyl-CCNU and irradiation: cell survival studies on a human tumor xenograft.
    Bateman AE; Fu KK; Towse GD
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1545-8. PubMed ID: 536260
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhanced cell killing in lewis lung carcinoma and a human pancreatic-carcinoma xenograft by the combination of cytotoxic drugs and misonidazole.
    Stephens TC; Courtenay VD; Mills J; Peacock JH; Rose CM; Spooner D
    Br J Cancer; 1981 Apr; 43(4):451-7. PubMed ID: 7236488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misonidazole enhancement of the action of BCNU and melphalan against human melanoma xenografts.
    Clutterbuck RD; Millar JL; McElwain TJ
    Am J Clin Oncol; 1982 Feb; 5(1):73-8. PubMed ID: 7081141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The growth of human tumours in immunosuppressed mice and their response to chemotherapy.
    Berenbaum MC; Sheard CE; Reittie JR; Bundick RV
    Br J Cancer; 1974 Jul; 30(1):13-32. PubMed ID: 4213444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phospholipid composition of small unilamellar liposomes containing melphalan influences drug action in mice bearing PC6 tumours.
    Large P; Gregoriadis G
    Biochem Pharmacol; 1983 Apr; 32(7):1315-8. PubMed ID: 6847720
    [No Abstract]   [Full Text] [Related]  

  • 12. The spectrum of chemosensitivity of two human pancreatic carcinoma xenografts.
    Courtenay VD; Mills J; Steel GG
    Br J Cancer; 1982 Sep; 46(3):436-9. PubMed ID: 6215052
    [No Abstract]   [Full Text] [Related]  

  • 13. The human tumour xenograft--a valid model in experimental chemotherapy?
    Shorthouse AJ; Smyth JF; Steel GG; Ellison M; Mills J; Peckham MJ
    Br J Surg; 1980 Oct; 67(10):715-22. PubMed ID: 6253000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attempts to induce a graft-versus-tumour reaction against AKR lymphomata, in isogenic mice, by injection of Melphalan and foreign immunologically competent cells.
    Denton PM; Symes MO
    Br J Cancer; 1969 Mar; 23(1):95-102. PubMed ID: 5768449
    [No Abstract]   [Full Text] [Related]  

  • 15. Carcinostatic activity of 4-hydroxy-2-pent-en-1-al against transplantable murine tumour lines.
    Conroy PJ; Nodes JT; Slater F; White GW
    Eur J Cancer (1965); 1975 Apr; 11(4):231-40. PubMed ID: 124656
    [No Abstract]   [Full Text] [Related]  

  • 16. Experimental chemotherapy of gastrointestinal carcinoma xenografts.
    Peckham MJ; Courtenay VD; Steel GG
    Cancer Treat Rev; 1979 Jun; 6 Suppl():43-50. PubMed ID: 498171
    [No Abstract]   [Full Text] [Related]  

  • 17. Cancer chemotherapy screening with experimental tumors which metastasize to lymph nodes.
    Tsukagoshi S; Sakurai Y
    Cancer Chemother Rep; 1970 Oct; 54(5):311-8. PubMed ID: 5514619
    [No Abstract]   [Full Text] [Related]  

  • 18. Clonogenic cell survival curves for human melanoma xenografts using agar diffusion chamber and lung colony assays.
    Selby PJ; Thomas JM
    Br J Cancer Suppl; 1980 Apr; 4():150-3. PubMed ID: 6932919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopa uptake by human melanomas maintained in immunosuppressed mice.
    Hutton IM; Tebbutt S; Castro JE
    Clin Oncol; 1977 Sep; 3(3):271-80. PubMed ID: 912963
    [No Abstract]   [Full Text] [Related]  

  • 20. The response of a human tumour xenograft to chemotherapy: intrinsic variation between tumours and its significance in planning experiments.
    Warenius HM; Freedman LS; Bleehen NM
    Br J Cancer Suppl; 1980 Apr; 4():128-32. PubMed ID: 6932916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.